Search

Your search keyword '"McClure, Sam"' showing total 34 results

Search Constraints

Start Over You searched for: Author "McClure, Sam" Remove constraint Author: "McClure, Sam"
34 results on '"McClure, Sam"'

Search Results

1. Effect of PCI on Health Status in Ischemic Left Ventricular Dysfunction: Insights From REVIVED-BCIS2

2. Impact of Anatomical and Viability-Guided Completeness of Revascularization on Clinical Outcomes in Ischemic Cardiomyopathy

3. Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction: Cost-Effectiveness Analysis of the REVIVED-BCIS2 Trial

4. Arrhythmia and Death Following Percutaneous Revascularization in Ischemic Left Ventricular Dysfunction: Prespecified Analyses From the REVIVED-BCIS2 Trial

5. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

6. Effect of PCI on Health Status in Ischemic Left Ventricular Dysfunction

7. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

8. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

9. Supplementary Data from Circulating Tumor Cells Are Associated with Recurrent Disease in Patients with Early-Stage Non–Small Cell Lung Cancer Treated with Stereotactic Body Radiotherapy

10. Screening and Brief Intervention for Alcohol Problems in a University Student Health Clinic

12. Circulating Tumor Cells Are Associated with Recurrent Disease in Patients with Early-Stage Non–Small Cell Lung Cancer Treated with Stereotactic Body Radiotherapy

13. Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes

14. Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome ODYSSEY OUTCOMES Trial

15. Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial

16. Effects of alirocumab on types of myocardial infarction : insights from the ODYSSEY OUTCOMES trial

17. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

18. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

19. Oil Barrel Pitcher

22. MY FINAL WORD.

23. INCLUSION, ECONOMICS, AND EQUALITY.

24. GRATITUDE AND LEADERSHIP.

25. CIVIL DISCOURSE AND LEADERSHIP. NOW.

26. THIS IS WHO WE ARE.

27. RE-THINK INCLUSION.

28. ACHIEVABLE EQUALITY.

29. JOIN NOW.

30. "OUT".

31. THE FUEL FOR MINNESOTA'S ECONOMIC RECOVERY: INCLUSION.

32. NOW MORE THAN EVER.

33. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

34. Drug-eluting stents and saphenous vein graft intervention.

Catalog

Books, media, physical & digital resources